Glaucoma News

The most-read FDA approval stories of 2021 include Tyrvaya nasal spray and Byooviz, the first ophthalmology biosimilar to receive FDA approval.

Belkin Vision has been selected to receive 17.5 million euros in grants and equity from the European Innovation Council Accelerator to aid in the development of its glaucoma laser, according to a company press release.

A 58-year-old white woman with primary angle closure suspect was referred to the New England Eye Center glaucoma service for elevated IOP after bilateral laser peripheral iridotomy.

The first patient in the Chinese portion of the Denali phase 3 clinical trial, investigating NCX 470 in patients with open-angle glaucoma or ocular hypertension, has been screened, according to a press release from Nicox.

The first patient has been enrolled in a trial investigating the stand-alone use of the Hydrus microstent in mild to moderate open-angle glaucoma, according to a press release from Ivantis.

Aerie and Santen have entered an agreement for Rhopressa and Rocklatan in Europe, China, India, Commonwealth of Independent State countries, parts of Latin America and Oceanic countries, according to a company press release.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Philip Bloom, MD, discusses the role of endoscopic cyclophotocoagulation in the surgical management of glaucoma.

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Brian Flowers, MD, discusses results of the Glaukos iStent infinite trial in patients with advanced glaucoma.

NEW ORLEANS — Patients with malignant glaucoma, or aqueous misdirection, who received surgical management were more likely to have better visual outcomes, according to a speaker at the American Academy of Ophthalmology meeting.

The MINIject MIGS device has been approved in Europe for patients with open-angle glaucoma, according to a press release from iSTAR Medical.